Premium
Management of chronic myeloid leukemia in children and adolescents: Recommendations from the Children's Oncology Group CML Working Group
Author(s) -
Athale Uma,
Hijiya Nobuko,
Patterson Briana C.,
Bergsagel John,
Andolina Jeffrey R.,
Bittencourt Henrique,
Schultz Kirk R.,
Burke Michael J.,
Redell Michele S.,
Kolb E. Anders,
Johnston Donna L.
Publication year - 2019
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.27827
Subject(s) - medicine , myeloid leukemia , disease , leukemia , pediatrics , oncology
Chronic myeloid leukemia (CML) accounts for 2‐3% of leukemias in children under 15 and 9% in adolescents aged 15‐19. The diagnosis and management of CML in children, adolescents, and young adults have several differences compared to that in adults. This review outlines the diagnosis and management of the underlying disease as well as challenges that can occur when dealing with CML in this patient population.